Sigma-Aldrich and Oxford BioMedica win key ruling in open biosystems patent Infringement dispute.
Publication Date: 01-SEP-07
Publication Title: BIOTECH Patent News
Format: Online

Read this article now
Try Goliath Business News - FREE!
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News
Free for 7 Days!

Tell Me More   Terms and Conditions

Purchase this article for $4.95

Description

Sigma-Aldrich (St. Louis, MO), a life science company dedicated to providing state-of-the-art chemical and biotechnology products to the world's researchers, and Oxford BioMedica (Oxford, England), a leading gene therapy company, announced that they received a key order confirming the strength and validity of intellectual property owned by Oxford BioMedica and licensed exclusively in the research field to Sigma-Aldrich. The ruling was part of the construction of patent claim terms in the patent infringement suit brought against Open Biosystems, Inc. The lawsuit, which is pending in the United States District Court for the Eastern District of Missouri, alleges that Open Biosystems infringes United States Patents 6,924,123...



More articles from BIOTECH Patent News
University of Southern California obtains United States patent., September 01, 2007
Celtrix obtains United States patent., September 01, 2007
Monsanto obtains United States patent., September 01, 2007
ProChon obtains United States patent., September 01, 2007
Degussa obtains United States patent., September 01, 2007

Looking for additional articles?
Click here to search our database of over 3 million articles.